Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

PCOS affects multiple organs and requires combined treatment with lifestyle changes, metformin, and oral contraceptives.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Genes and hormones cause hair loss, with four genes contributing equally.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Low testosterone may indicate severe COVID-19 in men.